Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02305264 : Imaging of Intracerebral Inflammation in MS
PhaseN/A
AgesMin: 18 Years Max: 65 Years
Eligibility
Inclusion criteria

Healthy volunteers (group I, n=20)

- Aged 18-65 years;

- Able to understand the objectives and procedures of the study, and who give inform
consent.

Patients with relapsing-remitting MS (group II, n=15)

- Aged 18-65 years

- Clinically definite MS according to McDonald revised criteria

- Less than 10 year of evolution

- No clinical relapse during the past 3 months

- Able to understand the objectives and procedures of the study, and who give inform
consent

Patients with progressive MS (group III and IV, n=15 per group)

- Aged 18-65 years

- Clinically definite MS according to McDonald revised criteria

- SPMS evolving since more than 10 years for group III (n = 15).

- PPMS evolving since less than 10 years for group IV (n=15).

- Each progressive patient should have experienced a significant progression during the
2 years preceding the inclusion (with an estimated progression of the EDSS score of
at least 0.5 point).

- No clinical relapse during the past 3 months

- Able to understand the objectives and procedures of the study, and who give inform
consent.

Exclusion criteria

- Any reason, which does not allow performing MRI: claustrophobia, pace-maker or
intra-ocular foreign body for example.

- For women: pregnancy, lactation, lack of efficient contraception. At visit 2, a
positive pregnancy test will lead to exclude the patient.

- Uncontrolled diabetes

- Current symptoms of severe or uncontrolled renal, hepatic, hematological,
gastrointestinal pulmonary or cardiac disease.

- Positive HIV test

- Prior participation in other research protocols or clinical care in the last year
such that radiation exposure would exceed the annual guidelines.

- Other chronic neurological disease.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02305264      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740